EA200300567A1 - Лечение состояний тревоги - Google Patents
Лечение состояний тревогиInfo
- Publication number
- EA200300567A1 EA200300567A1 EA200300567A EA200300567A EA200300567A1 EA 200300567 A1 EA200300567 A1 EA 200300567A1 EA 200300567 A EA200300567 A EA 200300567A EA 200300567 A EA200300567 A EA 200300567A EA 200300567 A1 EA200300567 A1 EA 200300567A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- treatment
- alarm conditions
- published
- search report
- international search
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24901000P | 2000-11-15 | 2000-11-15 | |
US26536201P | 2001-01-31 | 2001-01-31 | |
PCT/US2001/027801 WO2002040006A2 (en) | 2000-11-15 | 2001-11-06 | Treatment of anxiety disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
EA200300567A1 true EA200300567A1 (ru) | 2004-10-28 |
Family
ID=26939750
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200300567A EA200300567A1 (ru) | 2000-11-15 | 2001-11-06 | Лечение состояний тревоги |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1395253A2 (ko) |
JP (1) | JP2004529073A (ko) |
KR (1) | KR20030051812A (ko) |
CN (1) | CN1822825A (ko) |
AU (1) | AU2002217757A1 (ko) |
BR (1) | BR0115301A (ko) |
CA (1) | CA2426069A1 (ko) |
CZ (1) | CZ20031339A3 (ko) |
EA (1) | EA200300567A1 (ko) |
HR (1) | HRP20030384A2 (ko) |
IL (1) | IL155874A0 (ko) |
MX (1) | MXPA03004190A (ko) |
NO (1) | NO20032156D0 (ko) |
PL (1) | PL366119A1 (ko) |
SK (1) | SK5422003A3 (ko) |
WO (1) | WO2002040006A2 (ko) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CZ20032380A3 (en) * | 2001-03-06 | 2004-03-17 | Eli Lilly And Company | Inhibitor of monoamine uptake |
CN1674907A (zh) * | 2002-08-14 | 2005-09-28 | 法玛西亚普强责任有限公司 | 瑞波西汀在治疗热潮红中的用途 |
GB0309440D0 (en) * | 2003-04-25 | 2003-06-04 | Lilly Co Eli | Quinolone derivatives |
WO2004103356A2 (en) * | 2003-05-15 | 2004-12-02 | Eli Lilly And Company | Treatment of emotional dysregulation |
KR20060121178A (ko) * | 2003-12-12 | 2006-11-28 | 일라이 릴리 앤드 캄파니 | 일과성 전신 열감, 충동 조절 장애 및 일반적인 의학상태로 인한 인격 변화 치료용 선택적 노르에피네프린재흡수 억제제 |
WO2009089479A2 (en) | 2008-01-09 | 2009-07-16 | Mayo Foundation For Medical Education And Research | Inhibiting neurotransmitter reuptake |
US20120220665A1 (en) * | 2009-11-03 | 2012-08-30 | Mayo Foundation For Medical Education And Research | Inhibiting Neurotransmitter Reuptake |
WO2011056788A2 (en) * | 2009-11-03 | 2011-05-12 | Mayo Foundation For Medical Education And Research | Inhibiting neurotransmitter reuptake |
WO2014159251A2 (en) | 2013-03-14 | 2014-10-02 | Mayo Foundation For Medical Education And Research | Inhibiting neurotransmitter reuptake |
JP2022519541A (ja) * | 2019-02-01 | 2022-03-24 | ホフマン・テクノロジーズ・エルエルシー | 不安関連障害を処置するための組成物および方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2931997A (en) * | 1996-05-07 | 1997-11-26 | Merck & Co., Inc. | Treatment of mood disorders with a growth hormone secretagogue |
IT1305322B1 (it) * | 1998-04-23 | 2001-05-04 | Pharmacia & Upjohn Spa | Uso di reboxetina per il trattamento di disturbi nervosi |
ES2246485T3 (es) * | 1999-07-01 | 2006-02-16 | PHARMACIA & UPJOHN COMPANY LLC | (s,s)-reboxetina para tratar la incontinencia. |
-
2001
- 2001-11-06 EA EA200300567A patent/EA200300567A1/ru unknown
- 2001-11-06 EP EP01996376A patent/EP1395253A2/en not_active Withdrawn
- 2001-11-06 CN CNA01818927XA patent/CN1822825A/zh active Pending
- 2001-11-06 CA CA002426069A patent/CA2426069A1/en not_active Abandoned
- 2001-11-06 CZ CZ20031339A patent/CZ20031339A3/cs unknown
- 2001-11-06 AU AU2002217757A patent/AU2002217757A1/en not_active Abandoned
- 2001-11-06 BR BR0115301-3A patent/BR0115301A/pt not_active IP Right Cessation
- 2001-11-06 WO PCT/US2001/027801 patent/WO2002040006A2/en not_active Application Discontinuation
- 2001-11-06 IL IL15587401A patent/IL155874A0/xx unknown
- 2001-11-06 JP JP2002542380A patent/JP2004529073A/ja active Pending
- 2001-11-06 PL PL01366119A patent/PL366119A1/xx not_active Application Discontinuation
- 2001-11-06 KR KR10-2003-7006523A patent/KR20030051812A/ko not_active Application Discontinuation
- 2001-11-06 MX MXPA03004190A patent/MXPA03004190A/es unknown
- 2001-11-06 SK SK542-2003A patent/SK5422003A3/sk not_active Application Discontinuation
-
2003
- 2003-05-13 NO NO20032156A patent/NO20032156D0/no not_active Application Discontinuation
- 2003-05-14 HR HR20030384A patent/HRP20030384A2/xx not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
IL155874A0 (en) | 2003-12-23 |
CZ20031339A3 (cs) | 2003-10-15 |
CN1822825A (zh) | 2006-08-23 |
NO20032156L (no) | 2003-05-13 |
WO2002040006A3 (en) | 2003-12-24 |
AU2002217757A1 (en) | 2002-05-27 |
JP2004529073A (ja) | 2004-09-24 |
MXPA03004190A (es) | 2003-09-22 |
HRP20030384A2 (en) | 2003-08-31 |
BR0115301A (pt) | 2004-12-14 |
CA2426069A1 (en) | 2002-05-23 |
WO2002040006A2 (en) | 2002-05-23 |
EP1395253A2 (en) | 2004-03-10 |
KR20030051812A (ko) | 2003-06-25 |
NO20032156D0 (no) | 2003-05-13 |
PL366119A1 (en) | 2005-01-24 |
SK5422003A3 (en) | 2003-12-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200201214A1 (ru) | Замещенные тиоацетамиды | |
EA200000351A1 (ru) | Лечение кондуктивных нарушений | |
EA200300906A1 (ru) | Новые спиротрициклические производные и их применение в качестве ингибиторов фосфодиэстеразы-7 | |
EA200300105A1 (ru) | Нестероидные ингибиторы воспалений | |
DE60218493D1 (de) | Substituierte 7-aza-ä2.2.1übicycloheptane für die behandlung von krankheiten | |
IS2170B (is) | Sýklópentanóindól, efnablöndur sem innihalda slíkefnasambönd og meðhöndlunaraðferðir | |
HRP20010573B1 (en) | Tricyclic inhibitors of poly(adp-ribose) polymerases | |
EA200300528A1 (ru) | 1-арил-или 1-алкилсульфонилгетероциклилбензазолы в качестве лигандов 5-гидрокситриптамина-6 | |
NO20005237D0 (no) | Heterocyklisk substituerte amider anvendt som calpain- inhibitorer | |
EA200300836A1 (ru) | Производные фталазинон-пиперидина в качестве ингибиторов pde4 | |
EA200201252A1 (ru) | Соединения, эффективные в качестве агонистов э2 - адренорецептора и ингибиторов фосфодиэстеразы pde4 | |
EA200300567A1 (ru) | Лечение состояний тревоги | |
DE60231107D1 (de) | Tetrahydro-pyrazinoä1,2-aüindole für die behandlung von krankheiten des zentralnervensystems | |
RS51003B (sr) | Derivat piridin-1-oksida i postupak za njegovu transformaciju u farmaceutski efikasna jedinjenja | |
DE60325377D1 (de) | Motilidverbindungen | |
EA200200948A1 (ru) | Лечение псориаза | |
DE60033809D1 (de) | Inhibitoren von metalloproteinasen | |
DK1438034T3 (da) | Anvendelse af -phenyl-3-dimethylaminiopropanforbindelser til behandling af urininkontinens | |
EA200200798A1 (ru) | Кальцилитические соединения | |
DK1161239T3 (da) | 3- cyclopropylmethoxy-4-difluormethoxy-N-(3,5-dichlorpyrid-4-yl)benzamid til behandling af dissemineret sklerose | |
DE60228134D1 (de) | Substituierte hydrazone als hemmer von cyclooxygenase-2 | |
ATE345135T1 (de) | Tropan-derivate mit dopamin-wiederaufnahme-hemmer-wirkung für die behandlung von ischämischen erkrankungen | |
DK1455770T3 (da) | Anvendelse af norepinephringenoptagelsesinhibitorer til behandling af tic lidelser | |
DE60124791D1 (de) | S-Methyl-Dihydro-Ziprasidone zur Behandlung von psychiatrischen Störungen. | |
DE50209798D1 (de) | Substituierte 2-pyrrolidin-2-yl-1h-indol-derivative für die behandlung von migräne |